Molecular Analysis for Gastro-Esophageal Cancer: Multicenter Discrete Choice Experiment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorKU Leuven
About this trial
The goal of this survey is to investigate the participants' preference for a specific screening/diagnostic tool to detect and assess gastro-esophageal cancer.
The main question it aims to answer are:
* Which diagnostic modality is preferred by patients and the general population? * Which features of the diagnostic test are most detrimental in the decision-making for one or the other modality? * Are geographical differences present in regard to the preference for a diagnostic modality?
Participants will be asked to complete a survey of 20-25min, including a brief intake regarding their socio-economic status. This approach will allow us to correct for confounding factors.
Eligibility criteria
Qualifiers
Individuals >18yo to 75yo (upper age limit of Barrett's surveillance)
Access to computer or smartphone
Clear understanding of available languages of the experiment (English, French, Dutch, Spanish, German, Chinese, Japanese)
Disqualifiers
Individuals less than 18yo and more than 75yo
Incarcerated individuals
Trial design
Treatments tested in this trial
- Survey
Treatment groups
2,200 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov